Al-Razi Medical Co. (9572.SR) — Cash flow
Operating, investing, and financing cash flow for Al-Razi Medical Co. — annual and quarterly.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | 1↑101.7% | 0.53↓22.8% | 0.69↓65.9% | 2↓6.9% | 2 | |
| Depreciation & Amortization | 4↑141.2% | 1↓59.5% | 4↑37.7% | 3↑34.3% | 2 | |
| Deferred Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stock-Based Compensation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes in Working Capital | 0.15↓60.3% | 0.37↓40.2% | 0.62↑119.4% | -3↑50.9% | -7 | |
| Accounts Receivable | -2↓93.0% | -1↓1047.4% | -0.10↓354.9% | 0.04↑101.1% | -4 | |
| Inventory | -6↓280.3% | 3↑654.1% | 0.43↑108.1% | -5↓229.1% | -2 | |
| Accounts Payable | 0.00↑100.0% | -3↓561.9% | 0.59↓67.5% | 2↑267.7% | -1 | |
| Other Working Capital | 8↑614.4% | 1↑496.4% | -0.29↓219.9% | 0.24↑185.5% | -0.28 | |
| Other Non-Cash Items | 1.00↓61.0% | 3↑229.2% | 0.78↑41.0% | 0.55↓19.1% | 0.68 | |
| Net Cash from Operating Activities | 6↑17.5% | 5↓14.2% | 6↑184.4% | 2↑218.6% | -2 | |
| Operating Cash Flow | 6↑17.5% | 5↓14.2% | 6↑184.4% | 2↑218.6% | -2 | |
| Investing Activities | ||||||
| Investment in Property, Plant & Equipment | -2↑48.8% | -4↑23.9% | -5↓73.3% | -3↓153.7% | -1 | |
| Capital Expenditure | -2↑48.8% | -4↑19.1% | -5↓63.5% | -3↓153.7% | -1 | |
| Acquisitions | 0.00 | 0.00↓100.0% | 0.03 | 0.00 | 0.00 | |
| Purchases of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Sales & Maturities of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Investing Activities | 0.01↑161.2% | -0.01 | 0.00 | 0.00 | 0.00 | |
| Net Cash from Investing Activities | -2↑49.1% | -4↑23.3% | -5↓72.5% | -3↓153.7% | -1 | |
| Financing Activities | ||||||
| Net Debt Issuance | -2↓197.1% | 2↑176.2% | 0.72↑196.5% | -0.75↑62.9% | -2 | |
| Long-Term Net Debt Issuance | -2↓197.1% | 2↑176.2% | 0.72↑125.2% | -3↓42.2% | -2 | |
| Short-Term Net Debt Issuance | 0.00 | 0.00 | 0.00↑100.0% | -0.75 | 0.00 | |
| Net Stock Issuance | 0.00 | 0.00 | 0.00↑100.0% | -0.67↓105.4% | 12 | |
| Net Common Stock Issuance | 0.00 | 0.00 | 0.00↑100.0% | -0.67↓105.4% | 12 | |
| Common Stock Issuance | 0.00 | 0.00 | 0.00↑100.0% | -0.67↓105.4% | 12 | |
| Share Buybacks | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Preferred Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends Paid | 0.00 | 0.00↑100.0% | -2↓27.7% | -2 | 0.00 | |
| Common Dividends Paid | 0.00 | 0.00↑100.0% | -2↓27.7% | -2 | 0.00 | |
| Preferred Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Financing Activities | -2↑21.6% | -3↓851.2% | 0.40↑118.9% | -2 | 0.00 | |
| Net Cash from Financing Activities | -4↓321.0% | -1↑20.5% | -1↑76.3% | -5↓152.6% | 10 | |
| Cash Reconciliation | ||||||
| Effect of Foreign Exchange | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Change in Cash | -0.45↓781.4% | 0.07↑112.1% | -0.55↑91.3% | -6↓184.7% | 7 | |
| Cash at Beginning of Period | 0.77↑9.5% | 0.70↓44.1% | 1↓83.5% | 8↑6708.1% | 0.11 | |
| Cash at End of Period | 0.31↓59.3% | 0.77↑9.5% | 0.70↓44.1% | 1↓83.5% | 8 | |
| Income Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Free Cash Flow | 4↑252.6% | 1↑9.3% | 1.00↑211.7% | -0.89↑68.9% | -3 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.